The Collaborative Initial Glaucoma Treatment Study: Study design, methods, and baseline characteristics of enrolled patients

Ophthalmology

Volumn 106, Issue 4, 1999, Pages 653-662

  Musch, David C ^a,b   Lichter, Paul R ^a   Guire, Kenneth E ^a   Standardi, Carol L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FILTRATION; FOLLOW UP; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TRABECULECTOMY; VISUAL ACUITY; VISUAL FIELD;

EID: 0033511527     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(99)90147-1     Document Type: Article

References (39)

1. Migdal C, Hitchings R. Control of chronic simple glaucoma with primary medical, surgical and laser treatment. Trans Ophthalmol Soc UK 1986;105:653-6.
2. Jay JL, Murray SB. Early trabeculectomy versus conventional management in primary open angle glaucoma. Br J Ophthalmol 1988;72:881-9.
3. Jay JL, Allan D. The benefit of early trabeculectomy versus conventional management in primary open angle glaucoma relative to severity of disease. Eye 1989;3:528-35.
4. Sherwood MB, Grierson I, Millar L, Hitchings RA. Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon's capsule in glaucomatous patients. Ophthalmology 1989;96:327-35.
5. Watson PG. Immediate surgery for the treatment of open angle glaucoma? [editorial]. Eye 1989;3:VIII.
6. Lavin MJ, Wormald RPL, Migdal CS, Hitchings RA. The influence of prior therapy on the success of trabeculectomy. Arch Ophthalmol 1990;108:1543-8.
7. Ainsworth JR, Jay JL. Cost analysis of early trabeculectomy versus conventional management in primary open angle glaucoma. Eye 1991;5:322-8.
8. Migdal C, Hitchings R. The role of early surgery for open-angle glaucoma. Ophthalmology Clinics of North America 1991;4:853-9.
9. Hitchings RA. Primary surgery for primary open angle glaucoma - justified or not? Br J Ophthalmol 1993;77: 445-8.
10. Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile. Arch Ophthalmol 1994;112:1437-45.
11. Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol 1994;112: 1446-54.
12. Johnson DH, Yoshikawa K, Brubaker RF, Hodge DO. The effect of long-term medical therapy on the outcome of filtration surgery. Am J Ophthalmol 1994;117:139-48.
13. Migdal C, Gregory W, Hitchings R. Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology 1994;101: 1651-7.
14. Migdal C. What is the appropriate treatment for patients with primary open-angle glaucoma: medicine, laser, or primary surgery? Ophthalmic Surg 1995;26:108-9.
15. Stewart WC, Sine CS, LoPresto C. Surgical vs medical management of chronic open-angle glaucoma. Am J Ophthalmol 1996;122:767-74.
16. Lichter PR. Glaucoma therapy and quality of life. Ophthalmology Clinics of North America 1991;4:897-904.
17. O'Donoghue E. β blockers and the elderly with glaucoma: are we adding insult to injury? Br J Ophthalmol 1995;79:794-6.
18. Diggory P, Franks W. Medical treatment of glaucoma - a reappraisal of the risks. Br J Ophthalmol 1996;80:85-9.
19. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975;31:103-15.
20. Deyo RA, Inui TS. Toward clinical applications of health status measures: sensitivity of scales to clinically important changes. Health Serv Res 1984;19:277-89.
21. MacKenzie CR, Charlson ME, DiGioia D, Kelley K. Can the Sickness Impact Profile measure change? An example of scale assessment. J Chronic Dis 1986;39:429-38.
22. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Control Clin Trials 1991;12(4 Suppl):142S-158S.
23. The Advanced Glaucoma Intervention Study (AGIS): 1. Study design and methods and baseline characteristics of study patients. Control Clin Trials 1994;15:299-325.
24. Advanced Glaucoma Intervention Study. 2. Visual field test scoring and reliability. Ophthalmology 1994;101:1445-55.
25. Bailey IL, Lovie JE. New design principles for visual acuity letter charts. Am J Optom Physiol Opt 1976;53:740-5.
26. Ferris FL III, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol 1982;94: 91-6.
27. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics: ETDRS report number 7. Ophthalmology 1991;98(5 Suppl):741-56.
28. Sloane ME, Ball K, Owsley C, et al. The Visual Activities Questionnaire: developing an instrument for assessing problems in everyday visual tasks. Technical Digest 1992; 1:26-9.
29. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1977;1:385-401.
30. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981;19:787-805.
31. The Glaucoma Laser Trial (GLT). 3. Design and methods. Glaucoma Laser Trial Research Group. Control Clin Trials 1991;12:504-24.
32. Wilensky JT, Gandhi N, Pan T. Racial influences in open-angle glaucoma. Ann Ophthalmol 1978;10:1398-402.
33. Grant WM, Burke JF Jr. Why do some people go blind from glaucoma? Ophthalmology 1982;89:991-8.
34. Martin MJ, Sommer A, Gold EB, Diamond EL. Race and primary open-angle glaucoma. Am J Ophthalmol 1985;99:383-7.
35. Wilson R, Richardson TM, Hertzmark E, Grant WM. Race as a risk factor for progressive glaucomatous damage. Ann Ophthalmol 1985;17:653-9.
36. Tielsch JM, Sommer A, Katz J, et al. Racial variations in the prevalence of primary open-angle glaucoma: The Baltimore Eye Survey. JAMA 1991;266:369-74.
37. Sommer A, Miller NR, Pollack I, et al. The nerve fiber layer in the diagnosis of glaucoma. Arch Ophthalmol 1977;95: 2149-56.
38. Quigley HA, Katz J, Derick RJ, et al. An evaluation of optic disc and nerve fiber layer examinations in monitoring progression of early glaucoma damage. Ophthalmology 1992;99:19-28.
39. Zeyen TG, Caprioli J. Progression of disc and field damage in early glaucoma. Arch Ophthalmol 1993;111:62-5.